CRDF
CRDF
NASDAQ · Biotechnology

Cardiff Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.99
+0.00 (+0.17%)
As of Aug 15, 2:16 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +996.7% upside
Low Target $7.63
Average Target $10.81
High Target $13.89
Current Price $0.99
Current
$0.99
Target
$10.81
$7.63 $10.81 avg $13.89
Scenario Analysis
Bear Case
$7.63
674.1%
Low target
Base Case
$10.81
+996.7%
Avg target
Bull Case
$13.89
+1,309.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.31
-70.2% from high
52-Week Low
$0.76
+30.3% from low
Target vs 52W High
$10.81
+226.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%